Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy

This cross-sectional study identifies organizations engaged in lobbying related to the 340B Drug Pricing Program, estimates their lobbying expenditures, and characterizes their policy priorities.

Corresponding Author: Cooper Urban, BS, Department of Population Health, New York University Grossman School of Medicine, 550 First Ave, New York, NY 10016 (Cooper.Urban@nyulangone.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.